Journal of Hepatocellular Carcinoma

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Dynamic Landscape of Liver Transplantation and Hepatocellular Carcinoma" in the Journal of Hepatocellular Carcinoma.

There has been an ongoing evolution of the role of liver transplantation in the treatment of patients who have a diagnosis of hepatocellular carcinoma over the last four decades. From the beginnings of the Milan criteria to the use of liver transplantation as a salvage therapy for patients who have exhausted other medical and surgical interventions, we are living in a field that is rapidly changing. Newer immunotherapies and incorporating a multi-faceted approach to treat this disease subsequently expands the potential pool of patients who may ultimately require and will subsequently benefit from liver transplantation. Unfortunately the ongoing shortage of donor livers (both deceased and living) plays a role in the availability of liver transplantation as a treatment option. The impact of these therapies on liver transplant outcomes are intertwined and with the field rapidly growing it is important to look at the current state from a research and translational perspective. The following subjects fit within this call for papers:

• Salvage liver transplantation
• Pre-transplant immunotherapies
• Post-transplant HCC recurrence and treatment options
• Role of living donor liver transplant and HCC
• Portal vein tumor thrombus and liver transplantation

Please view the journal Aims and Scope and author submission guidelines. The deadline for submissions is 15 September 2024. 

Please submit your manuscript on our website, quoting the promo code PMOQM to indicate that your submission is for consideration in this Article Collection. Standard article publishing charges apply.

Guest advisor

David Gerber, Christian R. Holmes Memorial Chair of Surgery and Chair of the Department of Surgery, University of Cincinnati College of Medicine

Dr. Gerber received his medical degree from the University of Pittsburgh and completed general surgery training at Emory University in Atlanta, GA with a post-doctoral fellowship in Transplantation Immunology. He subsequently completed his clinical transplant fellowship at the Starzl Transplantation Institute at the University of Pittsburgh School of Medicine. Clinically he has expertise in solid organ transplantation with a focus on liver cancer including the integration of navigation into minimally invasive surgery procedures.

Dr. Gerber has received over 25 basic science grants including extramural funding from the National Institutes of Health, the American Liver Foundation, the Roche Organ Transplant Research Foundation, the American Society of Transplant Surgeons, and the American College of Surgeons. He has been principal investigator or co-investigator of more than 40 industry-sponsored clinical trials focusing on advancing patient outcomes in hepatocellular carcinoma and transplantation. He has published over 200 peer reviewed publications, peer-reviewed abstracts and book chapters in the areas of liver cancer, transplantation, stem cell biology, and regenerative medicine. In addition, he has received two patents and has given over 100 national and international presentations in healthcare and biotechnology.

View all papers in this article collection